https://www.selleckchem.com/pr....oducts/ziftomenib.ht
Severe thrombocytopenia (50 G/L) developed in 50 patients (29.6%), neutropenia (1 G/L) in 20 patients (11.8%) and severe anaemia (8 g/dL) in 21 patients (12.4%). At the end of treatment, 94% of patients with available stool examination (n = 132) had no spores detected. Among 99 patients with available follow-up after the end of treatment, three parasite relapses were documented. E. bieneusi microsporidiosis was mainly diagnosed in transplant recipients. Fumagillin was associated with haematological toxicity but showed hig
Aimer
Commentaire
Partagez
